Halodoc 获得印尼卫生部监管沙盒监督
This regulatory milestone in Indonesia is crucial for Halodoc's operations, providing a framework for supervised digital health innovation.
Regulatory approval/supervision for digital health platform.
This regulatory milestone in Indonesia is crucial for Halodoc's operations, providing a framework for supervised digital health innovation. It enhances trust and credibility for users and healthcare providers, potentially paving the way for broader adoption and integration of digital health services within the Indonesian healthcare system. The "supervised" status indicates compliance and a commitment to safe and effective digital health practices, which is vital for scaling in the APAC region.
This regulatory development is highly relevant to the APAC region, particularly Southeast Asia, as it addresses the growing need for clear guidelines and oversight in the rapidly expanding digital health sector. It sets a precedent for other countries in the region looking to foster innovation while ensuring patient safety and data privacy.
Halodoc 已获得印度尼西亚共和国卫生部监管沙盒计划的“受监督”地位。这标志着 Halodoc 与卫生部之间建立了牢固的合作伙伴关系和参与式监督，旨在保护数字健康创新组织者、消费者和医护人员。
此信号在行业全局中的位置。
https://novoholdings.dk/news/novo-holdings-increases-investment-in-halodoc-to-strengthen-indonesias-health-system
阅读完整来源精选情报直达收件箱。无垃圾邮件，随时退订。
登录后可保存信号笔记。
登录